Meeder Asset Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-39
| Closed | -$7K | – | 2573 |
|
|
2021
Q3 | $7K | Sell |
39
-1
| -3% | -$179 | ﹤0.01% | 1830 |
|
|
2021
Q2 | $5K | Hold |
40
| – | – | ﹤0.01% | 1979 |
|
|
2021
Q1 | $5K | Sell |
40
-5
| -11% | -$625 | ﹤0.01% | 1882 |
|
|
2020
Q4 | $6K | Sell |
45
-742
| -94% | -$98.9K | ﹤0.01% | 1185 |
|
|
2020
Q3 | $89K | Sell |
787
-4,743
| -86% | -$536K | 0.01% | 820 |
|
|
2020
Q2 | $528K | Buy |
5,530
+2,568
| +87% | +$245K | 0.03% | 352 |
|
|
2020
Q1 | $266K | Buy |
+2,962
| New | +$266K | 0.02% | 495 |
|
|
2019
Q2 | – | Sell |
-123
| Closed | -$6K | – | 2197 |
|
|
2019
Q1 | $6K | Sell |
123
-229
| -65% | -$11.2K | ﹤0.01% | 1376 |
|
|
2018
Q4 | $15K | Buy |
352
+229
| +186% | +$9.76K | ﹤0.01% | 1149 |
|
|
2018
Q3 | $7K | Sell |
123
-4
| -3% | -$228 | ﹤0.01% | 1264 |
|
|
2018
Q2 | $6.16K | Hold |
127
| – | – | ﹤0.01% | 1223 |
|
|
2018
Q1 | $5K | Sell |
127
-104
| -45% | -$4.09K | ﹤0.01% | 1252 |
|
|
2017
Q4 | $10K | Buy |
231
+62
| +37% | +$2.68K | ﹤0.01% | 1132 |
|
|
2017
Q3 | $6K | Sell |
169
-85
| -33% | -$3.02K | ﹤0.01% | 1232 |
|
|
2017
Q2 | $8K | Hold |
254
| – | – | ﹤0.01% | 1065 |
|
|
2017
Q1 | $7K | Buy |
254
+6
| +2% | +$165 | ﹤0.01% | 975 |
|
|
2016
Q4 | $6K | Buy |
+248
| New | +$6K | ﹤0.01% | 841 |
|